Curie.Bio
PrivateLast Round
Seed
Jan 29, 2025
Total Funding Raised
$862.1M
Company Overview
Curie.Bio is a biotechnology company that operates an accelerator to enhance the creation of viable therapeutics firms by assisting founders in securing financing and navigating the drug development process.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curie.Bio Comparables
Compare Curie.Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| JucaBio | 46% |
For institutional investors. Book with your work email.
Curie.Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 29, 2025 | ||||
| VC Round | Jun 26, 2024 | ||||
| Seed | Feb 14, 2023 |
For institutional investors. Book with your work email.
Curie.Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed |
| GV | Seed |
| 5AM Ventures | Seed |
| ARCH Venture Partners | Seed |
| Casdin Capital | Seed |
| Leaps by Bayer | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 14, 2023
$520M round led by GV
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- invests_intoSep 30, 2026
Curie.Bio participated in R1 Therapeutics, Inc.'s oversubscribed $77.5M Series A, co-led by Abingworth, DaVita Venture Group and F-Prime, when R1 Therapeutics, Inc. launched in Mar '26.
For institutional investors. Book with your work email.
Curie.Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Curie.Bio's valuation, stock price, and market status.
Is Curie.Bio a public or private company?
Curie.Bio is a private company.
What is the current stock price of Curie.Bio?
Curie.Bio is a private company, so its shares have no public market price. Caplight tracks Curie.Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Curie.Bio worth (valuation)?
Valuation information for Curie.Bio is not publicly available.
Can I buy Curie.Bio stock?
Curie.Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Curie.Bio's last funding round?
Curie.Bio's most recent funding round was Seed on January 29, 2025.
Who are the main investors in Curie.Bio?
Key investors in Curie.Bio include GV.
Will Curie.Bio IPO soon?
No public IPO plans have been announced for Curie.Bio.
How can I track Curie.Bio secondary market activity?
Caplight tracks bids, offers, and trades in Curie.Bio's shares on secondary markets.